i
Hepatitis B vaccination among adults with diabetes mellitus, United States, 2018
-
11 2021
-
-
Source: Am J Prev Med. 61(5):652-664
Details:
-
Alternative Title:Am J Prev Med
-
Personal Author:
-
Description:Background:
Hepatitis B vaccination is routinely recommended for adults with diabetes mellitus (DM) aged <60 years and for those aged ≥60 years at the discretion of their healthcare provider.
Purpose:
To assess hepatitis B vaccination coverage among adults with and without DM.
Methods:
Data from the 2014–2018 National Health Interview Survey were analyzed in 2020 to determine hepatitis B vaccination series completion (≥3 doses) among adults aged 18–59 and ≥60 years with DM. Multivariable logistic regression analysis was conducted to identify factors independently associated with hepatitis B vaccination among adults aged 18–59 and ≥60 years with DM.
Results:
Among adults aged 18–59 years with DM in 2018, 33.2% had received hepatitis B vaccination (≥3 doses), an increase of 9.7 percentage points from 2014 (p<0.05). Among adults aged ≥60 years with DM, coverage was 15.3% in 2018 and did not increase during 2014–2018. Coverage was not significantly different among adults with DM compared with those without DM, even after controlling for factors assessed. Among adults with DM aged 18–59 and ≥60 years, younger age, having some college or college education, having been tested for human immunodeficiency virus, being healthcare personnel, or having traveled to hepatitis B virus–endemic areas were independently associated with increased likelihood of vaccination.
Conclusions:
Self-reported hepatitis B vaccination coverage among adults with DM remains suboptimal. Healthcare providers should assess patients’ diabetes status, recommend and offer needed vaccinations to patients or refer them to alternate sites for vaccination.
-
Subjects:
-
Keywords:
-
Source:
-
Pubmed ID:34294463
-
Pubmed Central ID:PMC9077536
-
Document Type:
-
Funding:
-
Collection(s):
-
Main Document Checksum:
-
Download URL:
-
File Type: